Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Johannes Ott, Christian Egarter & Alex Aguilera. (2022) Dydrogesterone after 60 years: a glance at the safety profile. Gynecological Endocrinology 38:4, pages 279-287.
Read now
Read now
Petra Stute. (2021) Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman’s journey. Gynecological Endocrinology 37:8, pages 683-688.
Read now
Read now
Articles from other publishers (38)
Xiaoqian Di, Yanzhi Hao, Zibo Duan, Yucong Ma, Ying Cao, Zhanwang Tan, Cuimiao Song & Xiaohua Lin. (2023) Activation of SGK1/ENaC Signaling Pathway Improves the Level of Decidualization in Unexplained Recurrent Spontaneous Abortion. Reproductive Sciences 30:11, pages 3273-3284.
Crossref
Crossref
Kamaludin Dingle, Osama M. Kassem, Fawaz Azizieh, Ghadeer AbdulHussain & Raj Raghupathy. (2023) Quantitative analyses of cytokine profiles reveal hormone-mediated modulation of cytokine profiles in recurrent spontaneous miscarriage. Cytokine 164, pages 156160.
Crossref
Crossref
Asher Bashiri, Gabi Galperin, Atif Zeadna, Yael Baumfeld & Tamar Wainstock. (2023) Increased Live Birth Rate with Dydrogesterone among Patients with Recurrent Pregnancy Loss Regardless of Other Treatments. Journal of Clinical Medicine 12:5, pages 1967.
Crossref
Crossref
Elif Yıldız & Burcu Timur. (2023) The effects of dydrogesterone treatment on first-trimester aneuploidy screening markers and nuchal translucency in women with threatened miscarriage. Journal of Turkish Society of Obstetric and Gynecology 20:1, pages 16-21.
Crossref
Crossref
Nana Tetruashvili, Alice Domar & Asher Bashiri. (2023) Prevention of Pregnancy Loss: Combining Progestogen Treatment and Psychological Support. Journal of Clinical Medicine 12:5, pages 1827.
Crossref
Crossref
Yao Peng, Jiayuan Zhang, Tian Lan, Shengyue Liu, Tao Ye & Yongzhou Wang. (2022) Meta analysis of the effect of phloroglucinol combined with progesterone in the treatment of threatened miscarriage before 20 weeks of gestation: A protocol for a systematic review. Medicine 101:47, pages e31885.
Crossref
Crossref
Chun-xiao Dang, Ding Wang, Peng-fei Liu, Jin-xing Liu & Xiao Yu. (2022) Network pharmacological analysis and molecular docking of Huangqin-Baizhu herb pair in the treatment of threatened abortion. Medicine 101:36, pages e30417.
Crossref
Crossref
Jiao Yu, Dongshu Zhu, Cheng Zeng, Yangyang Zhang, Huixia Yang & Yang Xu. (2022) MicroRNA expression profiles in the granulosa cells of infertile patients undergoing progestin primed ovarian stimulation. European Journal of Obstetrics & Gynecology and Reproductive Biology 276, pages 228-235.
Crossref
Crossref
Alexander Katalinic, Lee P. Shulman, Jerome F. Strauss, Juan A Garcia-Velasco & John N. van den Anker. (2022) A critical appraisal of safety data on dydrogesterone for the support of early pregnancy: a scoping review and meta-analysis. Reproductive BioMedicine Online 45:2, pages 365-373.
Crossref
Crossref
Xuehong Chen, Xiaoxiao Qiu & Yaojuan Jin. (2022) Effects of Dydrogesterone Tablets Combined with Zishen Yutai Pills on Threatened Abortion in Early Pregnancy and Pregnancy Outcomes. Computational and Mathematical Methods in Medicine 2022, pages 1-8.
Crossref
Crossref
Nathalie F. Wang, Leif Bungum & Sven O. Skouby. (2022) What is the optimal luteal support in assisted reproductive technology?. Hormone Molecular Biology and Clinical Investigation 43:2, pages 225-233.
Crossref
Crossref
M. Cessot, B. Salle, E. Labrune, O. Walter, M. Benchaib & E. Fraison. (2022) Comparaison de la dydrogestérone avec une progestérone micronisée vaginale dans le transfert d’embryon frais en FIV/ICSI. Gynécologie Obstétrique Fertilité & Sénologie 50:6, pages 462-469.
Crossref
Crossref
L.G. Góes, F.L. Vilarino, E. Oba & E.F. Bondan. (2022) Review of the literature on corpus luteum insufficiency in women (2015–2020) and in domestic animals (1980–2020). Clínica e Investigación en Ginecología y Obstetricia 49:2, pages 100724.
Crossref
Crossref
Raj Raghupathy & Julia Szekeres-Bartho. (2022) Progesterone: A Unique Hormone with Immunomodulatory Roles in Pregnancy. International Journal of Molecular Sciences 23:3, pages 1333.
Crossref
Crossref
Gennady T. Sukhikh, Leila V. Adamyan, Svetlana O. Dubrovina, Igor I. Baranov, Vitaly F. Bezhenar, Andrey V. Kozachenko, Viktor E. Radzinsky, Mekan R. Orazov, Maria I. Yarmolinskaya & Jan I. Olofsson. (2021) Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study. Fertility and Sterility 116:6, pages 1568-1577.
Crossref
Crossref
Eleftherios G. Kaklamanos, Miltiadis A. Makrygiannakis & Athanasios E. Athanasiou. (2021) Does exogenous female sex hormone administration affect the rate of tooth movement and root resorption? A systematic review of animal studies. PLOS ONE 16:9, pages e0257778.
Crossref
Crossref
Marie-Pierre Piccinni, Raj Raghupathy, Shigeru Saito & Julia Szekeres-Bartho. (2021) Cytokines, Hormones and Cellular Regulatory Mechanisms Favoring Successful Reproduction. Frontiers in Immunology 12.
Crossref
Crossref
Yuval Atzmon, Nardin Aslih, Daniela Estrada, Asaf Bilgory, Adrian Ellenbogen & Einat Shalom-Paz. (2020) Comparable Outcomes Using Oral Dydrogesterone Vs. Micronized Vaginal Progesterone in Frozen Embryo Transfer: a Retrospective Cohort Study. Reproductive Sciences 28:7, pages 1874-1881.
Crossref
Crossref
Rushania I. Gabidullina, Ekaterina A. Koshelnikova, Tatiana N. Shigabutdinova, Evgenii A. Melnikov, Gulfiria N. Kalimullina & Angelina I. Kuptsova. (2021) Endometriosis: impact on fertility and pregnancy outcomes. Gynecology 23:1, pages 12-17.
Crossref
Crossref
Sanjana Rajgopal & Raj Raghupathy. (2020) Using the Immune System to Manage Immunologically-Mediated Pregnancy Loss. Annals of the National Academy of Medical Sciences (India) 57:01, pages 08-15.
Crossref
Crossref
Georg Griesinger, Christophe Blockeel, Elke Kahler, Claire Pexman-Fieth, Jan I. Olofsson, Stefan Driessen & Herman Tournaye. (2020) Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis. PLOS ONE 15:11, pages e0241044.
Crossref
Crossref
Lingjie Li, Yu Zhang & Fang Fang. (2020) Authors' reply re: Effect of progestogen for women with threatened miscarriage: a systematic review and meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology 127:10, pages 1305-1305.
Crossref
Crossref
L Li, Y Zhang, H Tan, Y Bai, F Fang, A Faramand, W Chong & Y Hai. (2020) Effect of progestogen for women with threatened miscarriage: a systematic review and meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology 127:9, pages 1055-1063.
Crossref
Crossref
Ghadeer AbdulHussain, Fawaz Azizieh, Ma’asoumah Makhseed & Raj Raghupathy. (2020) Effects of Progesterone, Dydrogesterone and Estrogen on the Production of Th1/Th2/Th17 Cytokines by Lymphocytes from Women with Recurrent Spontaneous Miscarriage. Journal of Reproductive Immunology 140, pages 103132.
Crossref
Crossref
Thiam Chye Tan, Chee Wai Ku, Lee Koon Kwek, Kai Wei Lee, Xiaoxuan Zhang, John C. AllenJr.Jr., Valencia Ru-Yan Zhang & Nguan Soon Tan. (2020) Novel approach using serum progesterone as a triage to guide management of patients with threatened miscarriage: a prospective cohort study. Scientific Reports 10:1.
Crossref
Crossref
E. S. Polushkina & R. G. Shmakov. (2020) The role of dydrogesterone in habitual miscarriage. Meditsinskiy sovet = Medical Council:3, pages 74-77.
Crossref
Crossref
Yuya Takeshige, Tomoko Hashimoto & Koichi Kyono. (2020) Dose-Dependent Chlormadinone Acetate Can Suppress Premature LH Surge in Parallel with LH Value Reduction. Fertility & Reproduction 02:01, pages 21-26.
Crossref
Crossref
Maria Emilia Solano & Petra Clara Arck. (2020) Steroids, Pregnancy and Fetal Development. Frontiers in Immunology 10.
Crossref
Crossref
Georg Griesinger, Herman Tournaye, Nick Macklon, Felice Petraglia, Petra Arck, Christophe Blockeel, Peter van Amsterdam, Claire Pexman-Fieth & Bart CJM Fauser. (2019) Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction. Reproductive BioMedicine Online 38:2, pages 249-259.
Crossref
Crossref
Li Sun, Zhengwei Yuan, Lingyan Jian, Qinghua Jiang, Siwen Zhang & Jichun Tan. (2019) The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-11.
Crossref
Crossref
N. A. Azizova. (2019) DURING PREGNANCY ON THE BACKGROUND OF RETROCHORIAL HEMATOMA. Bulletin of Problems Biology and Medicine 4:1, pages 13.
Crossref
Crossref
D. P. Kamilova, N. A. Yakunina & T. M. Ketiladze. (2019) Luteal phase support as one of key factors of success in assisted reproduction. Problemy reproduktsii 25:4, pages 51.
Crossref
Crossref
Georg Griesinger, Christophe Blockeel, Gennady T. Sukhikh, Ameet Patki, Bharati Dhorepatil, Dong-Zi Yang, Zi-Jiang Chen, Elke Kahler, Claire Pexman-Fieth & Herman Tournaye. (2018) Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial. Human Reproduction.
Crossref
Crossref
N. K. Tetruashvili & A. A. Agadzhanova. (2018) Dydrogesterone in the treatment of the threatened and habitual miscarriage. Medical Council:13, pages 68-72.
Crossref
Crossref
Helen Brown. (2018) Dydrogesterone: Shining New Light on Life. EMJ Reproductive Health, pages 51-57.
Crossref
Crossref
Hayfaa A Wahabi, Amel A Fayed, Samia A Esmaeil & Khawater Hassan Bahkali. (2018) Progestogen for treating threatened miscarriage. Cochrane Database of Systematic Reviews 2018:9.
Crossref
Crossref
Sha Yu, Hui Long, Hannah Ya-ning Chang, Yali Liu, Hongyuan Gao, Jing Zhu, Xinxin Quan, Qifeng Lyu, Yanping Kuang & Ai Ai. (2018) New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles. Human Reproduction 33:2, pages 229-237.
Crossref
Crossref
Herman Tournaye, Gennady T. Sukhikh, Elke Kahler & Georg Griesinger. (2017) A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Human Reproduction 32:5, pages 1019-1027.
Crossref
Crossref